SCHEMBL3908991

SCHEMBL3908991

Cc1cccnc1-c1cc(-c2cccnc2)cc2nc(N)nn12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.50
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NUDT1 P36639 2/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FYN P06241 3/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
GLO1 Q04760 1/20 0.38
DYRK3 O43781 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CDK5 Q00535 1/20 0.38
DYRK1A Q13627 1/20 0.38
CDK5R1 Q15078 1/20 0.38
DYRK2 Q92630 1/20 0.38
DYRK1B Q9Y463 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3919967 0.84 KDM4E (0.52) CYP2A6KDM4EALDH1A1SMN1; SMN2NUDT1
SCHEMBL3909975 0.84 KDM4E (0.57) CYP2A6KDM4EALDH1A1SMN1; SMN2NUDT1
SCHEMBL3911184 0.81 KDM4E (0.49) CYP2A6KDM4EALDH1A1SMN1; SMN2NUDT1
SCHEMBL3913834 0.81 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2NUDT1FYN
SCHEMBL3917455 0.80 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2NUDT1FYN
SCHEMBL3910497 0.80 KDM4E (0.46) CYP2A6KDM4EALDH1A1SMN1; SMN2NUDT1
SCHEMBL3910189 0.79 JAK2 (0.43) CYP2A6
SCHEMBL3911140 0.79 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2NUDT1NPC1
SCHEMBL3910529 0.78 ALDH1A1 (0.45) CYP2A6KDM4EALDH1A1SMN1; SMN2NUDT1
SCHEMBL3923734 0.78 DYRK1A (0.48) KDM4EALDH1A1SMN1; SMN2NUDT1FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524860-B2 Antibacterial agents PFIZER INC. (US) 2009-04-28 US disclosed
US-20080021059-A1 Antibacterial Agents PFIZER INC. (US) 2008-01-24 US disclosed
EP-1799680-A2 TRIAZOLOPYRIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS Warner-Lambert Company LLC (US) 2007-06-27 EP disclosed
WO-2006038116-A2 TRIAZOLOPYRIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY LLC (US) 2006-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021059-A1 Antibacterial Agents CLPP, QDPR, CLSPN CYP2A6 1897/4885KDM4E 3745/4885ALDH1A1 3118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.